Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001842952-25-000064)

Filing Details

Accession Number:: 0001842952-25-000064
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-10 17:26:21
Reporting Period:: 2025-06-09

Filing Date:: 2025-06-10
Accepted Time:: 2025-06-10 17:26:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1842952	Context Therapeutics Inc.	CNTX	Pharmaceutical Preparations (2834)	863738787

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1861989	A. Martin Lehr	2001 Market Street Suite 3915, Unit #15 Philadelphia PA 19103	Chief Executive Officer	Yes	Yes	No	No

Transaction Summary

Purchased:	100,000 shares	Avg. Price: $0.70	Total Value: $70,080.00
Number of Shares After Transactions:	920,190 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-06-09	100,000	$0.70	920,190	No	4	P	Indirect	Martin Lehr 2000 Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Martin Lehr 2000 Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	159,701	Direct

Footnotes

The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.6682 - $0.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.